“Tyrosine Kinase Inhibitors for EGFR- and ALK-Mutated Non-Small Cell Lung Cancer”. ADMET and DMPK 4, no. 3 (October 1, 2016): 186–211. Accessed May 26, 2026. https://pub.iapchem.org/ojs/index.php/admet/article/view/337.